This brief overview of the promoting roles of phosphatidylserine and sphingolipids in prostate tumorigenesis agrees with our findings that the increased expression of SERINC3, which potentiates their biosynthesis, represents a higher risk of disease progression for prostate cancer patients that are stratified according to the Gleason score. This evidence concerns the gene SERINC3 and prostate carcinoma.